VivoSeq
Other

Femoral Nerve Block

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Femoral Nerve Block is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

71/100

Attrition Rate

20/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

25

clinical trials

Completed12 · 48%
Unknown status7 · 28%
Terminated4 · 16%
Recruiting1 · 4%
Withdrawn1 · 4%

Trial Activity

25 trials

Ultrasound Guided Femoral Nerve Block
Completed··N/A·NCT02381717·44 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)